Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06707688 · ClinicalTrials.gov registry record · NA

Abbott Medical - VERITAS Study

A NA study of Atrial Fibrillation (AF) and Stoke, sponsored by Abbott Medical Devices.

Active
Registry status
NA
Development phase
458
Enrollment target
20
Study locations

NCT06707688 is a NA study of Atrial Fibrillation (AF) and Stoke that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 458 participants, below the 693-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (34% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06707688, a NA study of Atrial Fibrillation (AF) and Stoke, is active but no longer recruiting, sponsored by Abbott Medical Devices.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
458 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of this study is to evaluate the safety and effectiveness of Abbott's Amulet™ 2 Left Atrial Appendage (LAA) occluder device (Amulet 2 device) in patients who have non-valvular atrial fibrillation and who are at increased risk for stroke and systemic embolism and have appropriate rationale to seek a non-pharmacologic alternative to oral anticoagulation.

Conditions Studied

Atrial Fibrillation (AF) Stoke

Interventions

  • DEVICE Amulet™ 2 Left Atrial Appendage (LAA) Occluder

Study Locations (20)

Texas

  • Texas Cardiac Arrhythmia - Austin
  • Baylor Scott & White All Saints Medical Center - Fort Worth
  • Vital Heart and Vein - Humble
  • Baylor Scott & White - The Heart Hospital Plano - Plano
  • Heart Rhythm Associates - Shenandoah

Florida

  • Baptist Medical Center - Jacksonville
  • AdventHealth Orlando - Orlando

New York

  • NYU Langone Health - New York
  • Mount Sinai Hospital - New York

South Carolina

  • Roper Hospital - Charleston
  • Trident Medical Center - Charleston

Arizona

  • Arizona Arrhythmia Research Group - Phoenix

Arkansas

  • Arrhythmia Research Group - Jonesboro

Georgia

  • Northside Hospital - Atlanta

Kansas

  • Kansas City Cardiac Arrhythmia Research Foundation - Overland Park

Trial Details

FieldValue
Enrollment Target 458 participants
Start Date 2024-11-07
Est. Completion 2027-09
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06707688

The ClinicalTrials.gov registry entry for NCT06707688 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 458 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 693-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (34% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atrial Fibrillation (AF) appearing as the primary indexed condition, and to 1 intervention - of which Amulet™ 2 Left Atrial Appendage (LAA) Occluder is the first listed.

NCT06707688 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Texas, Florida, New York.

Frequently Asked Questions

What is clinical trial NCT06707688 about?

NCT06707688 is a clinical study titled "Abbott Medical - VERITAS Study". The primary objective of this study is to evaluate the safety and effectiveness of Abbott's Amulet™ 2 Left Atrial Appendage (LAA) occluder device (Amulet 2 device) in patients who have non-valvular atrial fibrillation and who are at increased risk for stroke and systemic embolism and have appropriat...

What is the current status of trial NCT06707688?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 458 participants. The study started on 2024-11-07. Estimated completion is 2027-09.

What conditions does trial NCT06707688 study?

This clinical trial studies the following conditions: Atrial Fibrillation (AF), Stoke.

What interventions are being tested in trial NCT06707688?

The interventions under investigation include: Amulet™ 2 Left Atrial Appendage (LAA) Occluder (DEVICE).

Who is sponsoring clinical trial NCT06707688?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06707688 being conducted?

This trial has 20 study locations across Arizona, Arkansas, Florida, Georgia, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation (AF)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation (AF)

All registered trials for this condition

Stoke

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.